Century Therapeutics

Revolutionary Leap in Biotherapy: Century Therapeutics’ Ground-Breaking Technology Proves Promising

PHILADELPHIA, PA — Emerging from the recent ASGCT 27th Annual Meeting, Century Therapeutics (NASDAQ: IPSC) has caught the attention of the medical world. The company revealed its innovative Allo-Evasionâ„¢ platform, …

Revolutionary Leap in Biotherapy: Century Therapeutics’ Ground-Breaking Technology Proves Promising Read More

Century Therapeutics

Century Therapeutics Announces Expansion and Significant Progress in Autoimmune and Cancer Therapies

PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC), a pioneer in developing induced pluripotent stem cell (iPSC) derived therapies, shared a promising update on its financial standing and strategic advancements …

Century Therapeutics Announces Expansion and Significant Progress in Autoimmune and Cancer Therapies Read More

Larimar Therapeutics

Larimar Therapeutics’ Promising Q1 2024 Results Show Potential Treatment for Friedreich’s Ataxia

BALA CYNWYD, PA — Larimar Therapeutics (Nasdaq: LRMR) recently unveiled its Q1 2024 operational and financial results. The biopharmaceutical company is making remarkable progress in the clinical program of their …

Larimar Therapeutics’ Promising Q1 2024 Results Show Potential Treatment for Friedreich’s Ataxia Read More